127 related articles for article (PubMed ID: 15300227)
1. Chromosome 12, frequently deleted in human pancreatic cancer, may encode a tumor-suppressor gene that suppresses angiogenesis.
Yamanaka S; Sunamura M; Furukawa T; Sun L; Lefter LP; Abe T; Yatsuoka T; Fujimura H; Shibuya E; Kotobuki N; Oshimura M; Sakurada A; Sato M; Kondo T; Matsuno S; Horii A
Lab Invest; 2004 Oct; 84(10):1339-51. PubMed ID: 15300227
[TBL] [Abstract][Full Text] [Related]
2. Suppression of the tumorigenic phenotype by chromosome 18 transfer into pancreatic cancer cell lines.
Lefter LP; Furukawa T; Sunamura M; Duda DG; Takeda K; Kotobuki N; Oshimura M; Matsuno S; Horii A
Genes Chromosomes Cancer; 2002 Jun; 34(2):234-42. PubMed ID: 11979557
[TBL] [Abstract][Full Text] [Related]
3. The role of chromosome 18 abnormalities in the progression of pancreatic adenocarcinoma.
Sunamura M; Lefter LP; Duda DG; Morita R; Inoue H; Yokoyama T; Yatsuoka T; Abe T; Egawa S; Furukawa T; Fukushige S; Oshimura M; Horii A; Matsuno S
Pancreas; 2004 Apr; 28(3):311-6. PubMed ID: 15084978
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of chromosome 18 in pancreatic cancer: strong evidence for new tumour suppressor genes.
Lefter LP; Sunamura M; Furukawa T; Yastsuoka T; Abe H; Inoue H; Abe T; Egawa S; Miura K; Morita R; Horii A; Matsuno S
Asian J Surg; 2004 Apr; 27(2):85-92. PubMed ID: 15140658
[TBL] [Abstract][Full Text] [Related]
5. Inserting chromosome 18 into pancreatic cancer cells switches them to a dormant metastatic phenotype.
Lefter LP; Sunamura M; Furukawa T; Takeda K; Kotobuki N; Oshimura M; Matsuno S; Horii A
Clin Cancer Res; 2003 Oct; 9(13):5044-52. PubMed ID: 14581380
[TBL] [Abstract][Full Text] [Related]
6. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.
Maruyama Y; Ono M; Kawahara A; Yokoyama T; Basaki Y; Kage M; Aoyagi S; Kinoshita H; Kuwano M
Cancer Res; 2006 Jun; 66(12):6233-42. PubMed ID: 16778198
[TBL] [Abstract][Full Text] [Related]
7. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
9. Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.
Bockhorn M; Tsuzuki Y; Xu L; Frilling A; Broelsch CE; Fukumura D
Clin Cancer Res; 2003 Sep; 9(11):4221-6. PubMed ID: 14519649
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumorigenicity of a murine squamous cell carcinoma (SCC) cell line by a putative tumor suppressor gene on human chromosome 7.
Zenklusen JC; Oshimura M; Barrett JC; Conti CJ
Oncogene; 1994 Oct; 9(10):2817-25. PubMed ID: 8084587
[TBL] [Abstract][Full Text] [Related]
11. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C
J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
[TBL] [Abstract][Full Text] [Related]
12. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
13. Mast cells and angiogenesis in pancreatic ductal adenocarcinoma.
Longo V; Tamma R; Brunetti O; Pisconti S; Argentiero A; Silvestris N; Ribatti D
Clin Exp Med; 2018 Aug; 18(3):319-323. PubMed ID: 29492715
[TBL] [Abstract][Full Text] [Related]
14. Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.
Roche S; O'Neill F; Murphy J; Swan N; Meiller J; Conlon NT; Geoghegan J; Conlon K; McDermott R; Rahman R; Toomey S; Straubinger NL; Straubinger RM; O'Connor R; McVey G; Moriarty M; Clynes M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32024004
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
16. The PMAIP1 gene on chromosome 18 is a candidate tumor suppressor gene in human pancreatic cancer.
Ishida M; Sunamura M; Furukawa T; Lefter LP; Morita R; Akada M; Egawa S; Unno M; Horii A
Dig Dis Sci; 2008 Sep; 53(9):2576-82. PubMed ID: 18231856
[TBL] [Abstract][Full Text] [Related]
17. Chmp1A functions as a novel tumor suppressor gene in human embryonic kidney and ductal pancreatic tumor cells.
Li J; Belogortseva N; Porter D; Park M
Cell Cycle; 2008 Sep; 7(18):2886-93. PubMed ID: 18787405
[TBL] [Abstract][Full Text] [Related]
18. KLF4 is a novel candidate tumor suppressor gene in pancreatic ductal carcinoma.
Zammarchi F; Morelli M; Menicagli M; Di Cristofano C; Zavaglia K; Paolucci A; Campani D; Aretini P; Boggi U; Mosca F; Cavazzana A; Cartegni L; Bevilacqua G; Mazzanti CM
Am J Pathol; 2011 Jan; 178(1):361-72. PubMed ID: 21224073
[TBL] [Abstract][Full Text] [Related]
19. Suppression of tumorigenicity of rat liver tumor cells by human chromosome 13: evidence against the involvement of pRb and BRCA2.
Rider MA; Butz GM; Ricketts SL; Newberry ST; Grisham JW; Coleman WB
Int J Oncol; 2002 Feb; 20(2):235-45. PubMed ID: 11788883
[TBL] [Abstract][Full Text] [Related]
20. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]